Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC)

Price 161.40p on 21-11-2024 at 09:41:25
Change -0.40p -0.25%
Buy 161.80p
Sell 161.60p
Buy / Sell PRTC Shares
Last Trade: Buy 1,266.00 at 161.40p
Day's Volume: 121,685
Last Close: 161.80p
Open: 162.20p
ISIN: GB00BY2Z0H74
Day's Range 161.40p - 163.20p
52wk Range: 139.00p - 238.50p
Market Capitalisation: £386m
VWAP: 162.72601p
Shares in Issue: 239m

Recent Trades History PureTech (PRTC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1,266 161.40p Automatic Execution
09:41:23 - 21-Nov-24
Buy* 158 161.40p Automatic Execution
09:41:23 - 21-Nov-24
Buy* 21 161.40p Automatic Execution
09:41:23 - 21-Nov-24
Buy* 2 161.40p Automatic Execution
09:41:23 - 21-Nov-24
Sell* 9 161.00p SI Trade
09:41:16 - 21-Nov-24
Buy* 2 161.40p Automatic Execution
09:39:10 - 21-Nov-24
Sell* 2 161.40p Automatic Execution
09:29:16 - 21-Nov-24
Sell* 148 161.60p Automatic Execution
09:27:16 - 21-Nov-24
Sell* 129 161.60p Automatic Execution
09:27:16 - 21-Nov-24
Sell* 2,248 162.00p Automatic Execution
09:27:16 - 21-Nov-24

Share Price History for PureTech

Time period:
to
Date Open High Low Close Volume

Share News for PureTech

PureTech Health investigates IPF disease burden amid treatment testing

9th Oct 2024 10:03

(Alliance News) - PureTech Health PLC on Wednesday said a new patient survey for people with idiopathic pulmonary fibrosis has provided new insights into disease burden and patient experience. Read More

PureTech Health celebrates KarXT approval by FDA for schizophrenia

27th Sep 2024 11:30

(Alliance News) - PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophrenia. Read More

LONDON MARKET OPEN: Indices green ahead of Fed inflation gauge

27th Sep 2024 09:09

(Alliance News) - Stock prices in London opened somewhat higher on Friday, as investors wait for the US personal consumption expenditure data, plus various European consumer price and confidence readings. Read More

LONDON BRIEFING: FTSE 100 called up, Merchants Trust beats benchmark

27th Sep 2024 07:59

(Alliance News) - European stocks were called to open higher on Friday, ahead of US personal consumption expenditure and other important US data. Read More

IN BRIEF: PureTech's Vor in promising findings in cancer trial

6th Sep 2024 18:07

PureTech Health PLC - Boston, Massachusetts-based biotechnology company - Founded entity Vor Bio, a clinical stage cell and genome engineering company, has received new clinical data from ongoing Phase 1/2 VBP101 study. The study looks at patients with relapsed or refractory acute myeloid leukaemia receiving trem-cel followed by the Mylotarg drug. Recent data demonstrated reliable engraftment, shielding from Mylotarg on-target toxicity, a broadened Mylotarg therapeutic window, and early evidence of patient benefit. Read More

FTSE 100 Latest
Value8,075.46
Change-9.61

Login to your account

Forgot Password?

Not Registered